This week on The Genetics Podcast, Patrick is joined by Zornitza Stark, Professor at the University of Melbourne and Co-Group Leader at the Murdoch Children’s Research Institute. Using early findings from the BabyScreen+ genomic newborn screening study, they examine feasibility, clinical impact, and family-wide implications beyond standard screening, and consider what these insights mean for infrastructure, policy, and equitable implementation at scale.
Show Notes:
0:00 Intro to The Genetics Podcast
01:00 Welcome to Zornitza
01:55 Methods and findings of the BabyScreen+ study
04:35 Scaling the BabyScreen+ study from pilot to population screening
07:46 Balancing benefits, risks, and downstream implications in genomic newborn screening
15:55 How the genes tested in BabyScreen+ were selected
19:00 Cascade testing and the family-wide implications of genomic newborn screening
22:05 What large-scale genomic newborn screening could reveal about penetrance
23:57 Expanding genomic newborn screening over time and addressing equity, scale, and long-term value
27:47 Rapid genomic sequencing in critically ill newborns from pilot studies to national implementation
34:32 Building evidence infrastructure to interpret variants and support reimbursement decisions
37:25 Why global data sharing in genomics requires policy alignment and sustained infrastructure investment
39:55 Current priorities and the future direction of genomics in Australia
42:14 Closing remarks
Find out more:
Please consider rating and reviewing us on your chosen podcast listening platform!
